SPARC signs license agreement with Tripoint Therapeutics for Elepsia XR tablets
SPARC will be eligible to receive tiered royalties ranging from 15 per cent to 50 per cent on net sales
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.